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Age carries a detrimental impact on T cell function. In the past decade, analyses of the
genome-scale transcriptional changes of T cells during aging have yielded a large amount
of data and provided a global view of gene expression changes in T cells from aged hosts
as well as subsets of T cells accumulated with age. Here, we aim to review the changes
of gene expression in thymocytes and peripheral mature T cells, as well as the subsets
of T cells accumulated with age, and discuss the gene networks and signaling pathways
that are altered with aging in T cells. We also discuss future direction for furthering the
understanding of the molecular basis of gene expression alterations in agedT cells, which
could potentially provide opportunities for gene-based clinical interventions.
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INTRODUCTION
Age carries a detrimental impact on T cell function. Age-associated
decline of T cell function is complex and occurs at multiple levels
(Haynes and Swain, 2006). Alteration in transcription is arguably
one of the most studied and identifiable age-associated change in
T cells. As part of the adaptation to a changing microenvironment
with age (Linton et al., 2005), T cells undergo substantial changes
in gene expression, resulting in enhanced or reduced aspects of
their functions (Pawelec et al., 2005; Weng, 2006). Reported age-
associated alterations in T cell functions include: increased cyto-
toxicity, enhanced secretion of inflammatory cytokines, reduced
antigen-induced proliferation, and a decrease in cell division. The
precise details of age-associated changes in transcription are begin-
ning to be revealed, but the functional significance of these tran-
scriptional alterations and their contribution to the age-associated
changes in T cell function have not been fully characterized. A
better understanding of the transcriptional changes in T cells that
are associated with aging is an essential first step toward further
functional assessment and eventual clinical interventions for older
adults.
The development of methods, such as microarrays, allow the
genome-scale assessment of gene expression and provide a means
to understand the scope and magnitude of gene expression changes
during aging (Prolla, 2005). The current commercially available
whole genome arrays (Agilent, Affymetrix, and Illumina) con-
tain the information of over 30,000 transcripts with most of the
annotated protein-coding genes of human and mouse, and read-
ily assess RNAs isolated from a few thousand to millions of cells.
With sufficient biological repeats and proper statistical tools (Hyatt
et al., 2006), the global gene expression pattern and significantly
enhanced or reduced expressed genes are promptly identified; this
provides sufficient transcriptional details to match the complexity
of the age-associated changes. However, connecting the individual
altered expressed genes to the altered functional networks and
signaling pathways with aging is a monumental task.
In the past a few years, studies of global gene expres-
sion in T cells with aging have evolved from analyzing whole
organ/tissue/whole populations of T cells to comparing well-
defined subsets of T cells from different lymphoid tissues or
organs, and from identification of significantly altered genes to
connecting the gene networks and signaling pathways that are
associated with these altered genes. The cumulative evidence shows
that age-related alterations of transcription in T cells can be found
in thymocytes (Lustig et al., 2007, 2009; Griffith et al., 2012), in
peripheral mature T cells (Remondini et al., 2010), and T cell sub-
sets (Fann et al., 2005; Mirza et al., 2011). Although neither the
causes nor the consequences of all the transcriptional changes in
T cells with age are currently known, the identification and val-
idation of these age-associated changes pave a new avenue for a
better understanding of cellular and functional alterations associ-
ated with aging. This information will be essential for developing
strategies to slow down or even reverse the course of T cell aging.
The purpose of this review is to summarize the age-associated
gene expression changes on a global level that have been observed
in recent studies of T cells and their subsets. We also discuss a
potential link between the transcriptional changes and functional
changes in aged T cells.
TRANSCRIPTIONAL CHANGES IN AGED THYMUS AND
PERIPHERAL BLOOD T CELLS
THYMOCYTES
Initial microarray experiments were focused on comparing gene
expression of the total organ/tissue/T cells between young and
old hosts (mouse and human). Global gene expression analysis
using total thymus from mice revealed that the largest number of
gene expression changes with age, within total thymus, occurred in
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Table 1 | List of genes that are expressed either lower or higher in aged than in youngT cells.
Down-regulated Up-regulated
Genes Subsets Reference Genes Subsets Reference
T cell receptor signaling pathway Cytokine/chemokine network
AKT3 h CD8 Cao et al. (2010) ACVR2A, IL15, TNFSF14 h CD8 Cao et al. (2010)
CD28 h CD4N, CD8CD28- Weng et al. (2009),
Czesnikiewicz-Guzik
et al. (2008)
Bmpr1a m CD4N, CD8N Mirza et al. (2011)
CD3G h CD8 Cao et al. (2010) Ccl1, Il5, Il9, Il3, Il21 m s-CD4N & CD8N Mirza et al. (2011)
DLG1 h CD8 Cao et al. (2010) Ccl17, Ccl20, Ccl22, Ccl24 m s-CD4N Mirza et al. (2011)
GRAP2 h CD8 Cao et al. (2010) Ccl21c, Ccl8, Csf2 m CD8N Mirza et al. (2011)
GRB2 h CD8CD28- Lazuardi et al. (2009) CCL3/Ccl3 h CD4, m CD4N Mirza et al. (2011), Chen et al.
(2003)
ITK h CD8 Cao et al. (2010) CCL4 h CD8CD28- Fann et al. (2005)
LCK h CD8 Cao et al. (2010) CCL5/Ccl5 h CD8, m CD4N,
CD8N
Cao et al. (2010), Mirza et al.
(2011)
MAPK1, MAPK14 h CD8 Cao et al. (2010) CCR1 h CD4 Mo et al. (2003), Yung and Mo
(2003)
NCK1 h CD8 Cao et al. (2010) CCR2/Ccr2 h CD4, m CD4N,
CD8N
Mirza et al. (2011), Mo et al.
(2003)
PDK1 h CD8CD28- Lazuardi et al. (2009) CCR3 h CD4 Yung and Mo (2003)
PIK3CD h CD8CD28- Lazuardi et al. (2009) CCR4/Ccr4 h CD4, CD4N, m
CD4N, s-CD8N
Czesnikiewicz-Guzik et al.
(2008), Mirza et al. (2011), Mo
et al. (2003), Yung and Mo
(2003)
SOS2 h CD8 Cao et al. (2010) CCR5/Ccr5 h CD4, CD4N, m
CD4N/CD8N
Czesnikiewicz-Guzik et al.
(2008), Mirza et al. (2011), Mo
et al. (2003), Yung and Mo
(2003)
CCR6, CXCR2, CXCR5 h CD4 Mo et al. (2003)
Cytokine/chemokine network CCR8 h CD4N Czesnikiewicz-Guzik et al.
(2008), Mo et al. (2003)
Ccl19 m s-CD4N Mirza et al. (2011) CD70, IL17RB h CD4N Czesnikiewicz-Guzik et al.
(2008)
Ccl22 m CD8N Mirza et al. (2011) CLCF1 h CD8CD28- Lazuardi et al. (2009)
Ccl24 m s-CD8N Mirza et al. (2011) Csd2, Cxcl11 m s-CD4N Mirza et al. (2011)
Ccr9 m CD4N, CD8N Mirza et al. (2011) Csf1, Cxcl10 m CD4N Mirza et al. (2011)
Cxcl1 m CD4N Mirza et al. (2011) Csf2ra, Cxcl2 m CD8N Mirza et al. (2011)
Cxcl10, Cxcl12 m CD8N Mirza et al. (2011) Csf3r m s-CD8N Mirza et al. (2011)
CXCR7, CXCR9 h CD4, CD8 Mo et al. (2003) CX3CR1 h CD8CD28- Lazuardi et al. (2009), Fann
et al. (2005)
Flt1 m s-CD8N Mirza et al. (2011) CXCL12 h CD4 Hernandez-Lopez et al. (2010),
Cane et al. (2012)
Ifna1 m CD8N, s-CD4N Mirza et al. (2011) Cxcl9 m CD8N, s-CD4N Mirza et al. (2011)
Ifna13 m CD8N Mirza et al. (2011) CXCR3/Cxcr3 h CD4, CD8, m
CD4N, CD8N
Cao et al. (2010), Mirza et al.
(2011), Mo et al. (2003)
Ifnab m CD4N Mirza et al. (2011) CXCR4 h CD4 Mo et al. (2003),
Hernandez-Lopez et al. (2010),
Cane et al. (2012)
Il12b, Kit, Pdgfb m s-CD4N Mirza et al. (2011) FAS, IFNGR1 h CD8CD28- Lazuardi et al. (2009)
(Continued)
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Table 1 | Continued
Down-regulated Up-regulated
Genes Subsets Reference Genes Subsets Reference
Cytokine/chemokine network Cytokine/chemokine network
Il12rb2 m s-CD8N Mirza et al. (2011) Ifng, Il10, Il4 m CD4N, CD8N Mirza et al. (2011)
Il17a, Il6 m s-CD8N Mirza et al. (2011) Il12rb1, Il13, Il5ra m CD4N Mirza et al. (2011)
Il6ra m CD4N Mirza et al. (2011) Il18r1, Il20ra, Il23r, Il7r m s-CD8N Mirza et al. (2011)
Kit m s-CD8N Mirza et al. (2011) Il18rap, Il1b m CD8N Mirza et al. (2011)
Ppbp m CD4N Mirza et al. (2011) Il19, Il24, Il2ra, Inhba m s-CD4N Mirza et al. (2011)
Tnfrsf21 m s-CD8N Mirza et al. (2011) Il1r2 m CD4N, s-CD4N,
CD8N
Mirza et al. (2011)
Tnfsf11a m CD8N Mirza et al. (2011) Il2, Il22, Il23a m s-CD8N Mirza et al. (2011)
Tpo m s-CD8N Mirza et al. (2011) Ltbr m CD4N, CD8N Mirza et al. (2011)
Xcr1 m CD4N, s-CD8N Mirza et al. (2011) Tnfrsf13c m CD4N Mirza et al. (2011)
Natural killer cell-mediated cytotoxicity Tnfsf13b, Tnfsf4, Tnfrsf17 m CD4N, CD8N Mirza et al. (2011)
Ifna1 m s-CD4N Mirza et al. (2011)
Klrd1, Klrk1 m s-CD4N Mirza et al. (2011) Natural killer cell-mediated cytotoxicity
Nfatc4 m s-CD4N Mirza et al. (2011) CD244 h CD8 Cao et al. (2010)
FAS h CD8CD28- Lazuardi et al. (2009)
Toll like receptor signaling pathway GZMB h CD8CD28- Lazuardi et al. (2009)
Cd86 m CD8N Mirza et al. (2011) IFNGR1 h CD8CD28- Lazuardi et al. (2009)
Cxcl10 m CD8N Mirza et al. (2011) ITGB2 h CD8 Cao et al. (2010)
Ifna1, Ifna13 m CD8N Mirza et al. (2011) KIR2DL3, KIR2DL4 h CD4N Czesnikiewicz-Guzik et al.
(2008)
Ifnab m CD4N Mirza et al. (2011) KIR2DL5A h CD8CD28- Lazuardi et al. (2009)
Il6 m s-CD8N Mirza et al. (2011) KIR2DS5 h CD8CD28- Lazuardi et al. (2009)
Irf7 m CD4N, s-CD8N Mirza et al. (2011) KIR3DL1 h CD8CD28- Lazuardi et al. (2009)
Lbp m CD4N Mirza et al. (2011) KIR3DL2 h CD4N, CD8CD28- Czesnikiewicz-Guzik et al.
(2008), Lazuardi et al. (2009)
Pik3cd m CD4N Mirza et al. (2011) KLRC3 h CD8CD28- Lazuardi et al. (2009)
Rela m CD4N Mirza et al. (2011) KLRD1 h CD8 Cao et al. (2010)
Tlr5, Tlr7 m s-CD8N Mirza et al. (2011) KLRG1 h CD8 Henson and Akbar (2009)
MAPK1 h CD8CD28- Lazuardi et al. (2009)
Cell cycle regulator NKG2D h CD4 Alonso-Arias et al. (2011)
CCND2, CCNH h CD8 Cao et al. (2010) PRF1 h CD8CD28- Lazuardi et al. (2009)
FZR1 h CD8 Cao et al. (2010) PTPN6 h CD8 Cao et al. (2010)
MAD1L1 h CD8 Cao et al. (2010) VAV3 h CD8CD28- Lazuardi et al. (2009)
MYC h CD8 Cao et al. (2010)
RAD21 h CD8 Cao et al. (2010) MAPK signaling pathway
RB1, RBL2 h CD8 Cao et al. (2010) DUSP2, DUSP5,DUSP6, DUSP10 h CD8 Cao et al. (2010)
SMAD2, SMAD4 h CD8 Cao et al. (2010) DUSP4 h CD8CD28- Lazuardi et al. (2009)
SMC3 h CD8 Cao et al. (2010) FAS h CD8CD28- Lazuardi et al. (2009)
STAG1 h CD8 Cao et al. (2010) FGFR1 h CD8 Cao et al. (2010)
TFDP2 h CD8 Cao et al. (2010) FLNA h CD8 Cao et al. (2010)
YWHAE,YWHAZ h CD8 Cao et al. (2010) GNA12 h CD8 Cao et al. (2010)
MAP3K1 h CD8CD28- Lazuardi et al. (2009)
Insulin signaling pathway MAP3K5 h CD8 Cao et al. (2010)
AKT3 h CD8 Cao et al. (2010) MAP3K8 h CD8 Cao et al. (2010)
BRAF h CD8 Cao et al. (2010) MAP4K1 h CD8 Cao et al. (2010)
FLOT2 h CD8 Cao et al. (2010) MAPK1 h CD8CD28- Lazuardi et al. (2009)
FOXO1 h CD8 Cao et al. (2010) NR4A1 h CD8 Cao et al. (2010)
GRB2 h CD8CD28- Lazuardi et al. (2009) RPS6KA5 h CD8 Cao et al. (2010)
(Continued)
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Table 1 | Continued
Down-regulated Up-regulated
Genes Subsets Reference Genes Subsets Reference
Insulin signaling pathway MAPK signaling pathway
IRS1, IRS2 h CD8 Cao et al. (2010) RRAS2 h CD8CD28- Lazuardi et al. (2009)
MAPK1 h CD8 Cao et al. (2010)
PDE3B h CD8 Cao et al. (2010) Toll like receptor signaling pathway
PIK3CD h CD8CD28- Lazuardi et al. (2009) Ccl3 m CD4N Mirza et al. (2011)
PIK3R2 h CD8 Cao et al. (2010) Ccl5 m CD4N Mirza et al. (2011)
PRKACB, PRKAR1A h CD8 Cao et al. (2010) Cd86 m CD4N Mirza et al. (2011)
RPS6KB1 h CD8 Cao et al. (2010) Cxcl10 m CD4N Mirza et al. (2011)
SOS2 h CD8 Cao et al. (2010) Tlr4 m CD4N Mirza et al. (2011)
h, Human; m, mouse; CD4N, CD4 naïveT cells; CD8N, CD8 naïveT cells; s-, TCR activated.
the categories of transcription regulators and enzymes, and were
mostly involved with cell growth, proliferation, and death (Lustig
et al., 2007). One of the more notable transcription regulators
that decreased expression with age was the glucocorticoid recep-
tor, which has been implicated in T cell development and survival
within the thymus. Also detected was an increased expression of
several heat shock proteins, which are necessary for cell survival.
A subsequent study focused specifically on thymocytes, demon-
strated age-associated changes in the expression of genes involved
in TCR signaling, antigen presentation, and lymphocyte develop-
ment and function (Lustig et al., 2009). These age-related changes
included increased expression of CXCR4 and CXCR6, as well as a
decrease in CCL25. Another key change was an increase in Vav1,
which is important for T cell development and activation. Genes
involved with cell function included changes in various ribosomal
proteins, which could indicate changes in translational activity
with age, and a decrease in S100A, a calcium-binding protein
involved in various cell functions. Interestingly, increased gene
expression was consistent in genes associated with cancer.
An unexpected and significant difference was found in gene
expression analyses of the immunoglobulin gene family from
the thymus of old and young mice (Lustig et al., 2007). This
observation has been noted in various gene expression studies
(Schumacher et al., 2008; Swindell, 2009), even though some of
these studies focused specifically on thymocytes or splenic T cells.
Further analysis revealed the apparent presence of immunoglob-
ulin on the cell surfaces of thymocytes as well as splenic T cells,
but not intracellularly, indicating this might be an autoreactive
phenomenon occurring with age (Lustig et al., 2009).
Not surprisingly, the age-associated change of the environment
in which each T cell is located has an effect on the gene expression
profile of thymocytes. Griffith et al. (2012) demonstrated that the
most profound age-associated changes in gene expression (up to
30% of the genes) were found in the thymic stroma, and such
changes affected gene expression changes in all subsets of thymo-
cytes, which only had expression changes in about 3–4% of their
total genes. However, the small proportion of changes within the
developing thymocytes could be the most critical ones involved in
T cell aging.
MATURE T CELLS IN THE PERIPHERY
Changes in gene expression with age, specifically within the murine
spleen, mirrored the overall trends of other organs; these included
an increase in immune response, stress, and apoptosis related
genes, along with a decrease in genes involved in cell growth,
energy utilization, and lipid and carbohydrate metabolism (Schu-
macher et al., 2008). An interesting observation was that many of
these expression patterns were similar between mouse strains with
shortened, normal, or longer life spans, but the changes occurred
at a pace relative to the expected life span for each strain.
Sole focus on gene expression analyses of T cells purified from
mouse spleens showed critical gene expression changes in the old
mice that may be responsible for their alterations in T cell function
(Han et al., 2006). The authors found that old T cells express higher
Socs3 and lower growth factor independent 1 (Gfi-1) compared to
young T cells, which could contribute to the age-associated decline
in proliferation. They also found the increase of apoptosis in old
T cells could be explained by higher Gadd45 and lower Bcl2 in
old T cells compared to young T cells. In addition, the authors
observed an age-associated increase in many immunoglobulin-
associated genes, as well as genes associated with innate immunity,
such as lysozyme M and myeloperoxidase; moreover, this study
showed a decrease in TCR-associated genes such as TCR-beta
and various isoforms of Cd3, indicating that both the innate
and adaptive arms of the immune system are involved in aging
trends. Other categories of genes affected included structural pro-
teins, calcium-binding proteins, and genes involved in electron
transport.
Three basic patterns of changes in gene expression emerged
from a study of T cells in peripheral blood of various aged adults:
first, some genes increased in middle age then decreased; sec-
ond, genes that decreased in middle age then increased, and lastly,
some genes decreased with age (Remondini et al., 2010). Inter-
estingly, they found no group of genes that only increased with
age. Global clustering analysis revealed that the gene expression
pattern in “successfully aged” adults (older than 90 years) more
closely matched the patterns of the younger groups. Most of
the genes involved in T cell signaling were in the group which
increased in middle age, then decreased. Although it is difficult
Frontiers in Immunology | T Cell Biology May 2013 | Volume 4 | Article 121 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chen et al. Transcriptional changes of T cell aging
FIGURE 1 | Age-related alteration of gene expression in theTCR
signaling pathway.The age-related genes were assembled from the
literature based on the significant changes reported by the original articles
which were applied for all figures (Chen et al., 2003; Mo et al., 2003; Yung
and Mo, 2003; Fann et al., 2005; Czesnikiewicz-Guzik et al., 2008; Henson
and Akbar, 2009; Lazuardi et al., 2009; Weng et al., 2009; Cao et al., 2010;
Hernandez-Lopez et al., 2010; Alonso-Arias et al., 2011; Mirza et al., 2011;
Cane et al., 2012). Three-hundred five up-regulated and 472
down-regulated genes in aged human T cells including CD4 and CD8 T
cells were analyzed using KEGG analysis in the WEB-based GEne SeT
AnaLysis Toolkit (WebGestalt). The entire TCR signaling pathway is included
and the molecules with lower gene expression compared with young are
highlighted in red text and different border color indicating specific T cell
subsets. The altered expressed genes in the TCR signaling pathway
include CD3G, LCK, GRAP2 (encode GADS), GRB2, ITK, NCK, MAPK
signaling pathway molecules SOS2 and MAPK1 (encode Erk), CD28,
PI3K-AKT signaling pathway molecules PI3K, PDK1, and AKT, DLG1
(encode DLGH1) and MAPK14 (encode p38).
to strictly compare the patterns between the human and mouse
studies with age, some common genes are evident. Not surpris-
ingly, these genes are associated with TCR signaling, cytokines and
their receptors, and cancer-related genes. Other common genes
between human and mouse that changed expression with age
included those from more general signaling pathways, such as
Jak/Stat, PPAR, and mTOR signaling. This agrees with the obser-
vation that changes in gene expression occurring within aging T
cells mirror changes occurring in other cell types throughout the
body.
Genome-wide analyses of transcription alterations identified
the change associated with aging as a whole of either tissue or of
total T cells. As lymphoid tissue consists of different types of cells
(T and B cells, stromal cells, etc.), total T cells also consist of differ-
ent subsets (naïve, effector, and memory), it is unknown whether
the identified age-associated changes are a result of aging in all
types of cells or in a specific type of cell or a subset of a cell type.
Therefore, it is necessary to further analyze the gene expression
changes with age in defined a defined cell type, such as T cells, and
their subsets.
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GENE EXPRESSION CHANGES OF T CELL SUBSETS IN AGED
SUBJECTS
HUMAN CD4 T CELLS
Although a global comparison of gene expression in naïve CD4
T cells with age is not available, a study comparing global gene
expression of memory CD4 T cells (CD45RA−) between young
(20–30 years old) and old (70–75 years old) human subjects show
that the overall gene expression profiles of CD4 memory T cells
are similar (Czesnikiewicz-Guzik et al., 2008). Based on the fold
change (> or <1.25), 536 genes were identified as age-related,
including up-regulated genes such as HLA region genes, CCR4,
CCR8, CD26, CD58, IL17Rb, and LAIT1, and down-regulated
genes such as CD28, CCR6, KLRB1, and KLRC2.
Another recent study compared gene expression of CD4 T cells
between young and old donors after in vitro stimulation (Bektas
et al., 2013). This study focused on examining changes in TCR-
inducible gene expression via the NF-κB pathway, and found that
most NF-κB target genes are not induced in a sustained manner
in CD4 T cells from older compared to younger donors. Those
genes that failed to exhibit sustained expression include CXCL10,
TNFAIP2,CCL2, and CXCL5. On the other hand,a subset of NF-κB
target genes such as CXCL1, CXCL11, IL1a, and IL6, continue to be
up-regulated even in the absence of NF-κB induction. IL1 and IL6
are associated with a chronic pro-inflammatory state in the elderly
and are dysregulated in CD4 T cells from old donors. In addition,
the authors identified some immune function-related genes that
were highly induced after 2 h of stimulation in old donors, includ-
ing cell surface receptor and signaling molecules (SAMD4A, CD83,
KCTD12, SOCS1, and CTLA4) and effector molecules (GZMH ).
Interestingly, some of the most noteworthy age-associated changes
in murine models, such as up-regulation of the chemokines CCL3
and CCL4 and the cytokine IFN-γ, were not found in CD4 T cells
of old donors in this study (Chen et al., 2003; Han et al., 2006; Mirza
et al., 2011). Further studies are needed to determine the similari-
ties and differences between mouse and human in age-associated
changes in T cells.
The finding of low expression of CD28 in memory CD4 T cells
from aged donors leads to further comparison of gene expres-
sion between CD28+ and CD28− memory CD4 T cell subsets in
selected old donors (65–75 years old) (Czesnikiewicz-Guzik et al.,
2008). CD28 is a co-stimulatory receptor that offers a critical sig-
nal for complete T cell activation during T cell receptor initiation.
Absence of the CD28 signal causes partial T cell activation or even
anergy. Strikingly, it was found that the difference in gene expres-
sion between CD28+ and CD28−memory CD4 T cells was greater
than that of memory CD4 T cells between young and old subjects.
CD28− memory CD4 T cells express high levels of several KIR
genes and some surface receptors genes (CD70, CD74, and CCR5),
but low levels of TCRB, CD27, IL7R, IL9R, and ICAM2. Although
loss of CD28 protein expression with aging is mainly found in CD8
T cells, this study shows that reduced expression of CD28 mRNA
is also found in CD4 T cells with aging.
HUMAN CD8 T CELLS
A global comparative analysis of gene expression in human CD8 T
cells isolated from young (23–27 year old) and old (65–81 year
old) adults reported the identification of a total of 754 genes
(505 down-regulated and 258 up-regulated) using an expression
fold change more than 1.5 (Cao et al., 2010). The functions of
these genes are involved in the regulation of transcription, protein
phosphorylation, ubiquitination, intracellular transport, immune
response, and apoptosis. Intriguingly, the down-regulated genes
in CD8 T cells from old donors affect multiple stages of gene
transcription: chromatin structure, transcription initiation, elon-
gation, RNA stabilization, and protein translation and transloca-
tion; this suggests the impaired regulation of these fundamental
molecular events might be responsible for the declined immune
function in the elderly. In addition, genes related to the sig-
naling pathways are also found down-regulated in CD8 T cells
from old donors, such as T cell receptor signaling, IL-2 signal-
ing, IGF-1 signaling, insulin receptor signaling, JAK/Stat signal-
ing, MAPK/JNK signaling, PI3K/AKT signaling, Wnt/β-catenin
signaling, and ERK/MAPK signaling. On the other hand, oxida-
tive phosphorylation and apoptosis signaling are up-regulated in
CD8 T cells from old donors. These alterations of gene expression
provide a mechanism for the functional decline of the immune
response in the elderly.
CD28− CD8 T CELLS
Accumulation of CD28− CD8 T cells is one of the hallmarks
of human aging. The CD28− population is considered as aged
CD8 T cells in humans (Weng et al., 2009). The study of CD28+
and CD28− memory CD8 T cells (CD45RA−) from young and
middle aged donors (25–45 years old) identified <100 altered
genes/transcripts based on the criteria of the false discovery rate
(FDR)<0.05 and fold change>2 (Fann et al., 2005). Among these
45 genes,CD28− CD8 T cells highly expressed natural killer cell
receptors, GZMB, PRF1, FASLG, IL12A, IL12, CCL4, CX3CR1, and
CMKLR1. In contrast, they had low expression of IL3, IL23A, IL7R,
and IL12RB2.
A subsequent study comparing CD28+ and CD28− CD8 T cells
from young and old donors found that gene expression patterns
of CD28− CD8 T cells from young and old subjects were similar
(Lazuardi et al., 2009). In contrast, there were noticeable differ-
ences in gene expression of CD28+ CD8 T cells between young
and old subjects. From the gene expression similarities, the lev-
els from CD28+ CD8 T cells in old donors were located between
young CD28+ and CD28− (young and old) CD8 T cells. The highly
expressed genes identified by Fann et al. (2005) in CD28− CD8 T
cells were also found in this study. In addition, high expression of
PIK3CD, MAL, IL6R, CD62L, and CCR7 were found in CD28+
CD8 T cells of young subjects whereas high expression of GATA3,
BIRC3, FAS, RGS1, and MAP3K1 were found in CD28+ CD8 T
cells of old subjects. This study reveals that CD28− CD8 T cells
have a common pattern of gene expression regardless of whether
they are isolated from young or old subjects. However, whether
the difference in gene expression in CD28+ CD8 T cells between
young and old subjects is reflecting the impact of aging or the het-
erogeneous nature (different percentages of naïve and memory T
cells) of CD28+ CD8 T cells in young and old subjects remains to
be determined.
Interestingly, similarly reduced expression of some co-
stimulatory molecules including CD28, NK cell receptor, and
chemokine receptors were found in both CD4 and CD8 CD28−
Frontiers in Immunology | T Cell Biology May 2013 | Volume 4 | Article 121 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chen et al. Transcriptional changes of T cell aging
T cells with some differences in the expression of CD40L, KLRD1,
KLRG1, and KLRK1 (Czesnikiewicz-Guzik et al., 2008). However,
loss of CD28 surface expression was only prominent in CD8 T
cells with aging. Further studies will be needed to compare the
functional alteration of CD4 and CD8 subsets with aging.
MOUSE CD4 AND CD8 T CELLS
Studies in mouse T cells suggest that aging has a more profound
detrimental impact on naïve compared to memory T cells (Pon-
nappan and Ponnappan, 2011). Gene expression comparison of
naïve CD4 and CD8 T cells between young (3–4 months) and
old (20 months) mice identified over 2000 age-associated genes in
CD4 and CD8 T cells using a twofold change as the cutoff (Mirza
et al., 2011). The functions of these genes are broad and involved
in multiple cellular functions such as cell growth, cell cycle, cell
death, inflammatory response, and cell trafficking. Some of those
identified genes exhibited similar changes in both CD4 and CD8 T
cells from old mice, such as Anxa1, Ccl1, Ccl5, Ccr2, Il4, Havcr2, and
Ltb4r1. The enhanced expression of chemokines and chemokine
receptors in aged mouse T cells was also observed in an earlier
study (Mo et al., 2003). Some gene alterations are specific to either
CD4 or CD8 T cells, such as Jak3, Socs1, and Pi3kcd in CD4, and
Penk, Nfc2, and Irak3 in CD8 T cells of old mice.
Gene expression analysis of in vitro stimulated naïve T cells
between young and old mice further revealed some defects in T
cell signaling, cytokine production, and differentiation into Th2
cells. Gata3 and c-Maf were found up-regulated post-activation in
naïve aged CD4 T cells, which may be responsible for the imbal-
anced Th2 immune response in the elderly. Ccl5 and Tlt4 are
up-regulated in aged CD8 T cells from pre- to post-activation,
while Ccl1, Ccl9, Il7r, and other genes are only up-regulated post-
activation. Genes such as Tnfsf14 and S100a9 are up-regulated in
aged CD8 T cells only in pre- and 12 h post-activation. In CD4 aged
T cells, Ccl5 and Tlr4 are up-regulated at all timepoints. Rorc is
not differentially expressed before activation, however its expres-
sion was decreased in aged CD4 T cells compared with young
ones after TCR activation. In the pattern of lower expression in
the elderly at both pre- and post-activation, many genes associ-
ated with microtubules, cell cycle replication, migration, and other
functions were found in both CD4 and CD8 naïve T cells. Taken
together, the highly expressed and up-regulated specific cytokines,
chemokines, and their receptors in aged naïve T cells indicate that
naïve CD4 and CD8 T cells in old mice have a pro-inflammatory
status.
GENE NETWORKS AND PATHWAYS ALTERED IN AGED T
CELLS
A global view of gene expression profiles provides a means for
examining the gene networks and signaling pathways of a defined
biological process and function. Among the genes that were
transcriptionally altered in aged T cells, substantial numbers of
them are associated with basic cellular and molecular biologi-
cal processes such as cell growth and proliferation, cell death
and apoptosis, energy utilization and metabolism, and transcrip-
tion regulation, which were also reported in other types of cells
with aging (Kuilman et al., 2010). In Table 1, we combine the
altered expressed genes from the literature based on their original
selection and listed seven functional categories. We will focus on
the molecular basis of three immune function-related alterations
in T cells with aging in this review.
REDUCED EXPRESSION OF TCR AND CO-STIMULATION SIGNALING
ASSOCIATED GENES
Impaired TCR signal transduction was observed in aged mice and
humans two decades ago (Utsuyama et al., 1993; Whisler et al.,
1996). Genes associated with several TCR signaling pathways were
found to be expressed lower in aged hosts on both genome-scale
(Table 1; Figure 1) and individual studies. First, CD3G expression
was lower in human CD8 T cells (Cao et al., 2010), and phos-
phorylated Cd3z was decreased in aged mouse CD4 T cells, and
almost absent in 18-month old mice (Garcia and Miller, 1997).
Second, significantly reduced expression of CD28, particularly in
CD8 T cells, was widely reported in humans with aging (Weng
et al., 2009). Lower expression of CD28 was also found in human
CD4 memory cells but to a much lower degree compared to CD8 T
cells (Czesnikiewicz-Guzik et al., 2008). Intriguingly, several age-
associated defects in TCR signaling occur at the post-translational
level without obvious changes in the level of gene expression, such
as: reduced phosphorylation of phospholipase Cγ1 (PLCγ1), JNK,
second messengers such as inositol trisphosphate (IP3) and dia-
cylglycerol (DAG), reduced influx of Ca2+ (Utsuyama et al., 1997;
Kirk et al., 1999) in T cells of aged mice, decreased LCK activity
(Fulop et al., 1999), and ERK phosphorylation in T cells of aged
humans (Li et al., 2012). The consequence of these age-associated
changes in TCR signaling is observed at the transcriptional lev-
els of their downstream targets, such as the decreased expression
of SOS, GADS, NKC, ITK, PI3K, PDK2, AKT, Erk, Dlgh1, and
p38 (Table 1) (Utsuyama et al., 1993; Whisler et al., 1996). Cer-
tainly, more studies are needed to dissect the primary causes of the
impaired expression of these age-related genes and their functional
consequences.
ALTERATION OF CYTOKINES/CHEMOKINES NETWORK
Alteration of expression of various cytokines, chemokines, and
their receptors in CD4 or CD8 T cells from old humans
and mice are well documented (Table 1; Figure 2). Unlike
the age-associated TCR signaling pathway, enhanced expres-
sion of various cytokines of the TNF and TGF-β families,
chemokines (CCL3, CCL4, CCL5, CXCL12), and chemokine recep-
tors (CCR1, CCR2, CCR3, CCR4, CCR5, CCR6, CCR8, CXCR2,
CXCR3, CXC4, CXCR5) were reported in CD4 or CD8 T cells
from old humans and mice (Mo et al., 2003; Yung and Mo,
2003; Fann et al., 2005; Lazuardi et al., 2009; Cane et al.,
2012).
Age-related enhanced expression of cytokines and their recep-
tors include IL15, IL17RB, TNF family members (TNFSF7 and
TNFSF14), and receptors (FAS, TNFRSF18, and TNFSF1B), IFN
family receptor IFNGR1, and TGF-β family receptors ACVR2A.
Most of these genes are involved in the inflammatory response,
which could be the result of an increased inflammatory state dur-
ing some chronic infections. Chemokine CXCL12 and its recep-
tor CXCR4 are involved in regulating thymocyte development
and differentiation from DN (CD44−CD25+, CD44−CD25−)
to DP stages (Ara et al., 2003), but their roles in aged T
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FIGURE 2 | Age-related alteration of gene expression regarding
cytokine–cytokine receptor interactions.The gene families of
chemokines, interferon, TGFβ, IL17, and TNF are included and the
molecules with higher or lower gene expression compared with young are
highlighted in red and blue text, respectively. The different border color
indicates specific T cell subsets.
cells have not been determined. In general, the high levels
of expression of chemokines/chemokine receptors lead to an
enhanced T cell chemotactic response and different patterns of
tissue migration/residency of T cells in the old subjects (Cane
et al., 2012). It is unclear whether such changes are a result
of an increased inflammatory state and/or some chronic infec-
tion. Regardless, it is apparent this age-related change in T
cell chemokine expression has an important functional conse-
quence.
ENHANCED GENE EXPRESSION RELATED TO NK CELLS FUNCTION
Enhanced expression of a cluster of genes associated with NK cell
function is one of the most profound age-related changes in T
cells, especially in human CD28− CD8 T cells (Table 1; Figure 3);
it includes killer cell lectin-like receptors (KLR, KLRC3, KLRD1,
and KLRG1), killer cell immunoglobulin-like receptors (KIR2DL3,
KIR2DL4, KIRDL5A, KIR2DS5, KIR3DL1, and KIR3DL2), and
CD244. Although these genes were primarily expressed in NK
cells, aged memory, or CD28− T cells appear to increase their
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FIGURE 3 | Age-related alteration of gene expression regarding NK
cell-mediated cytotoxicity. NK cell-mediated cytotoxicity was present
and the molecules with higher gene expression compared with young
were highlighted in red text. The different border color indicates specific T
cell subsets. The altered expressed genes associated with NK mediated
cytotoxicity in aged T cells include receptors KIR3DL1, KIR3DL2,
KIR2DL, KIR2DS, KLRD1 (encode CD94), ITGB2, NKG2C/E, CD244
(encode 2B4), IFNGR, IFNSR, and FAS, signaling molecules PTPN6
(SHP-1), VAV and MARK1 (ERK1), and effector molecules GZMB and PRF1
(encode Perforin).
expression. Since CD28− cells are a unique subset of T cells in
older humans, the acquired expression of NK cell receptors and
some cytotoxic molecules (GZMB and PRF1) might reflect chronic
infection and an increased inflammatory state (Fann et al., 2005).
Another possibility is that gaining expression of NK receptors,
especially KIRs, might be a compensation for a shrinking TCR
repertoire in aged hosts (Abedin et al., 2005; Vallejo, 2006) since
KIR recognizes MHC-I/Ag complex with lower affinity compared
with that of TCR and was found only in the later stage of prolifer-
ative lifespan of oligoclonal T cells (Snyder et al., 2004). If this is
true, aged T cells with a high level of NK cell receptors can function
in both an MHC-restricted and non-restricted manner.
CONCLUSION
In the past decade, we have learned enormously from the global
gene expression analysis of aged T cells. Alteration of several
gene networks and pathways that are associated with aged T
cells have now been identified in humans and mice, including
T cell receptor and activation-related molecules, alteration of
chemokine/chemokine receptor expression, gain of NK cell recep-
tors and functions, and etc. Whether these identified alterations of
gene expressions occur in all cells or in subsets of defined T cell
populations remains to be determined. It is sufficient to say these
alterations contribute to the overall decline of T cell function.
It is worth mentioning that not all microarray data, especially
for some of the early studies, have the highest quality. The short-
comings include: incomplete gene list of the array used, insufficient
number of biological repeats, and lack of standardized selection
criteria of significantly altered genes. It is necessary in future stud-
ies to use the whole genome microarray chips with better designed
experiments, such as using defined cell populations, standardized
stimulation conditions and time, sufficient numbers of the biolog-
ical repeats, and proper statistical tools for selection of significantly
altered genes. In addition, future studies will need to dissect which
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specific stage of T cell development and differentiation these
changes occurred. The precise relationship of gene expression
change and function is essential for a better understanding these
age-associated alterations in T cell functions.
The current commercial whole genome microarray chips
offered by Agilent,Affymetrix, and Illumina have greatly improved
from a few years ago, and become a standard method for global
gene expression analysis. However, some shortcomings are also
emerging with recent developments. Most of the microarray chips
for gene expression analysis do not include miRNA and lncRNA,
both of which serve critical biological functions and in which
some alterations with aging and cell differentiation were recently
reviewed (Gorospe and Abdelmohsen, 2011; Guttman et al., 2011).
These microarray chips also do not provide information on dif-
ferent splicing isoforms of transcribed genes; thus, global tran-
scriptional assessment by the traditional microarray method does
not offer complete transcriptional information. RNA-Seq, a rel-
atively new method based on next-generation sequencing, can
readily address these shortcomings and provide more complete
transcriptional analysis.
Identification of the alteration of several gene networks and
pathways that are associated with aged T cells paves a way for
further functional assessment and potential clinical interventions.
Although the general approach such as supplementation of Vita-
min E in mice showed some promising results, such as increased
expression of genes involved in cell cycle regulation (Ccnb2, Cdc2,
and Cdc6) and higher up-regulation of expression in old T cells
following stimulation, a more focused approach targeting spe-
cific genes and gene networks that are altered in aged T cells may
offer a more direct and specific treatment. With the advancement
of the tools that can be used in manipulating gene expression in
cells, experimental determination and verification of these specific
genes/gene networks based therapeutic approach is feasible and
will lead to the development of novel drugs that could postpone
or even reverse the changes associated with aging in T cells.
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